Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab

• Main Authors: Gwenaelle Mulot (Author), Mehdi Benchaib (Author), Frank Plaisant (Author), Dominique Ploin (Author), Yves Gillet (Author), Etienne Javouhey (Author), Olivier Claris (Author), Jean-Charles Picaud (Author), Jean-Sebastien Casalegno (Author), Marine Butin (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

IntroductionPreterm infants are at risk of lower respiratory tract infections (LRTI), including Respiratory Syncytial Virus (RSV) associated bronchiolitis, for which palivizumab prophylaxis can be proposed. Our aim was to determine risk factors of very severe RSV disease in children born before 34 w...